HomeTagsNeurological diseases

neurological diseases

Healthcare

FDA approves QALSODY as the first treatment targeting a genetic cause of ALS

PR Newswire - April 28, 2023

Ionis Pharmaceuticals, Inc. announced that its partner Biogen has received U.S. Food and Drug Administration (FDA) approval of QALSODY 100 mg/15mL injection for the...

Biotechnology

Harmony Biosciences to be Added to the Nasdaq Biotech Index

PR Newswire - December 20, 2021

Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, announced that it has...